News: Chimerix Inc (CMRX.OQ)
28 Aug 2015
Thu, May 7 2015
NEW YORK, May 7 - Johnson & Johnson will become the first pharmaceutical company to formally seek advice from outside medical ethicists on "compassionate use" requests, in which desperate patients ask drugmakers to let them take an experimental medication, the company announced on Thursday.
- Chimerix Inc (CMRX) CEO Michelle Berrey on Q2, 2015 Results - Earnings Call Transcript
- Premarket Biotech Digest: Sanofi And Cholesterol, Novartis Misses, An Alzheimer's IPO
- Is The BioCryst Pharmaceuticals (BCRX) Recent Surge Irrational Exuberance?
- Chimerix's (CMRX) CEO Michelle Berrey on Q1 2015 Results - Earnings Call Transcript
- Next Week In Biotech: ASCO Abstracts, Pernix PDUFA, Celladon Earnings
- Chimerix (CMRX) Stock Declined Today Following Wider Than Expected Quarterly Loss